Wu Hao, Ji Qing-Jie, Xu Yu-Yang, Zhu Jian-Wei
Department of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People's Republic of China.
Clin Cosmet Investig Dermatol. 2024 Apr 12;17:843-846. doi: 10.2147/CCID.S455060. eCollection 2024.
Pityriasis rosea (PR) is a common inflammatory, erythematous and scaly skin condition that usually affects individuals aged from 20 to 40 years old. The disease often exhibits a self-limiting course up to 6-8 weeks. We report a 25-year-old female patient with a six-month history of red scaly rashes on the trunk and proximal limbs, accompanied by severe pruritus that has been remained ineffective conventional treatments. She was diagnosed as persistent pityriasis rosea. As abrocitinib has been proved to be effective for many inflammatory diseases, therefore in this case, we tried abrocitinib for the patient, and a good result had been achieved.
玫瑰糠疹（PR）是一种常见的炎症性、红斑鳞屑性皮肤病，通常影响20至40岁的人群。该病通常呈自限性病程，持续6 - 8周。我们报告一名25岁女性患者，其躯干和近端肢体出现红色鳞屑皮疹已有6个月病史，伴有严重瘙痒，常规治疗无效。她被诊断为持久性玫瑰糠疹。由于阿布昔替尼已被证明对多种炎症性疾病有效，因此在本病例中，我们对该患者试用了阿布昔替尼，并取得了良好效果。
